Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-TIGIT Antibody (5L133) (Synonyms: Vstm3, T cell immunoreceptor with Ig and ITIM domains, ENSMUSG000000715...)

Catalog No. TMAY-01329 Copy Product Info
🥰Excellent
Anti-TIGIT Antibody (5L133) is a Rabbit antibody targeting TIGIT. Anti-TIGIT Antibody (5L133) can be used in ELISA.

Anti-TIGIT Antibody (5L133)

Copy Product Info
🥰Excellent
Catalog No. TMAY-01329
Synonyms Vstm3, T cell immunoreceptor with Ig and ITIM domains, ENSMUSG00000071552

Anti-TIGIT Antibody (5L133) is a Rabbit antibody targeting TIGIT. Anti-TIGIT Antibody (5L133) can be used in ELISA.

Anti-TIGIT Antibody
(5L133)
Pack SizePriceUSA StockGlobal StockQuantity
100 μL$1987-10 days7-10 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-TIGIT Antibody (5L133) is a Rabbit antibody targeting TIGIT. Anti-TIGIT Antibody (5L133) can be used in ELISA.
SynonymsVstm3, T cell immunoreceptor with Ig and ITIM domains, ENSMUSG00000071552
Ig Type
Rabbit IgG
Clone
5L133
Reactivity
Human
Specificity
Human TIGIT
Application
Recommended Dose
ELISA: 1:5000-1:10000
Antibody Type
Monoclonal
Host SpeciesRabbit
ConstructionThis antibody was obtained from a rabbit immunized with purified, recombinant Human TIGIT (rh TIGIT; NP_776160.2Met1-Phe138).
PurificationProtein A
AppearanceLiquid
Formulation0.2 μm filtered solution in PBS
Research BackgroundTIGIT, also known as V-set and transmembrane domain-containing protein 3 (VSTM3) or V-set and immunoglobulin domain-containing protein 9 (VSIG9) is a new surface protein containing an immunoglobulin variable domain, a transmembrane domain and an immunoreceptor tyrosine-based inhibitory motif (ITIM). TIGIT is expressed on regulatory, memory, activated T cells and NK cells. It binds PVR with high affinity, and PVRL2 with lower affinity, but not PVRL3. Knockdown of TIGIT with siRNA in human memory T cells did not affect T cell responses, however, TIGIT inhibits NK cytotoxicity directly through its ITIM. TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. The binding of PVR to TIGIT on human dendritic cells enhanced the production of IL-1 and diminished the production of IL-12p4. Also, TIGIT counter inhibits the NK-mediated killing of tumor cells and protects normal cells from NK-mediated cytotoxicity thus providing an "alternative self" mechanism for MHC class I inhibition.Cancer ImmunotherapyCo-inhibitory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint TargetsImmunotherapyTargeted Therapy
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Immunogen
Recombinant Protein: Human TIGIT Protein
Antigen Species
Human
Biology Area
ITIM/ITAM Immunoreceptors and Related Molecules, Cancer Drug Targets
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free.
TransportShipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Keywords

Related Tags: buy Anti-TIGIT Antibody (5L133) | purchase Anti-TIGIT Antibody (5L133) | Anti-TIGIT Antibody (5L133) cost | order Anti-TIGIT Antibody (5L133)